NO20080131L - Fremgangsmate for rensing av IL-18 bindende protein - Google Patents

Fremgangsmate for rensing av IL-18 bindende protein

Info

Publication number
NO20080131L
NO20080131L NO20080131A NO20080131A NO20080131L NO 20080131 L NO20080131 L NO 20080131L NO 20080131 A NO20080131 A NO 20080131A NO 20080131 A NO20080131 A NO 20080131A NO 20080131 L NO20080131 L NO 20080131L
Authority
NO
Norway
Prior art keywords
binding protein
purification
purified
fluid
production
Prior art date
Application number
NO20080131A
Other languages
English (en)
Other versions
NO340957B1 (no
Inventor
Henri Kornmann
Original Assignee
Ares Trading Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ares Trading Sa filed Critical Ares Trading Sa
Publication of NO20080131L publication Critical patent/NO20080131L/no
Publication of NO340957B1 publication Critical patent/NO340957B1/no

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/281—Sorbents specially adapted for preparative, analytical or investigative chromatography
    • B01J20/286—Phases chemically bonded to a substrate, e.g. to silica or to polymers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/30—Processes for preparing, regenerating, or reactivating
    • B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
    • B01J20/3231—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the coating or impregnating layer
    • B01J20/3242—Layers with a functional group, e.g. an affinity material, a ligand, a reactant or a complexing group
    • B01J20/3244—Non-macromolecular compounds
    • B01J20/3246—Non-macromolecular compounds having a well defined chemical structure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/006—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
    • C07K9/008—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
    • B01D15/3804—Affinity chromatography

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

Oppfinnelsen vedrører en fremgangsmåte for fremstilling av renset IL-18 bindende protein (IL-18BP) fra et fluid som omfatter affinitetskromatografi.
NO20080131A 2005-06-10 2008-01-08 Anvendelse av IL-18 bindende protein samt fremgangsmåte for rensing av proteinet NO340957B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05105124 2005-06-10
US69041405P 2005-06-14 2005-06-14
PCT/EP2006/063029 WO2006131550A1 (en) 2005-06-10 2006-06-08 Process for the purification of il-18 binding protein

Publications (2)

Publication Number Publication Date
NO20080131L true NO20080131L (no) 2008-03-07
NO340957B1 NO340957B1 (no) 2017-07-31

Family

ID=34940147

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20080131A NO340957B1 (no) 2005-06-10 2008-01-08 Anvendelse av IL-18 bindende protein samt fremgangsmåte for rensing av proteinet

Country Status (17)

Country Link
US (1) US8217152B2 (no)
EP (1) EP1891088B1 (no)
JP (1) JP5091127B2 (no)
AT (1) ATE529433T1 (no)
AU (1) AU2006256763B2 (no)
CA (1) CA2610804C (no)
CY (1) CY1112312T1 (no)
DK (1) DK1891088T3 (no)
ES (1) ES2375831T3 (no)
HR (1) HRP20110948T1 (no)
IL (1) IL187935A (no)
NO (1) NO340957B1 (no)
PL (1) PL1891088T3 (no)
PT (1) PT1891088E (no)
RS (1) RS52273B (no)
SI (1) SI1891088T1 (no)
WO (1) WO2006131550A1 (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5171033B2 (ja) 2003-03-11 2013-03-27 メルク セローノ ソシエテ アノニム ｍＣＭＶＩＥ２プロモーターを含んで成る発現ベクター
ES2384241T3 (es) * 2003-05-13 2012-07-02 Merck Serono Sa Variantes activas de la proteína que fija IL-18 y usos médicos de las mismas
PT1675956E (pt) 2003-10-21 2010-11-04 Merck Serono Sa Sequência mínima de adn que actua como um isolador de cromatina e sua utilização na expressão de proteína
RS50516B (sr) 2003-11-05 2010-05-07 Ares Trading S.A. Prečišćavanje il-18 vezujućeg proteina
PT1720979E (pt) 2004-03-01 2007-10-25 Ares Trading Sa Utilização de um meio de cultura de células sem soro para a produção de il-18bp em células de mamífero
US7439336B2 (en) 2004-06-29 2008-10-21 Ares Trading S.A. Process for the purification of IL-18 binding protein
GB0416699D0 (en) 2004-07-27 2004-09-01 Prometic Biosciences Ltd Prion protein ligands and methods of use
PL1885753T3 (pl) * 2005-06-03 2011-12-30 Ares Trading Sa Wytwarzanie rekombinowanego białka wiążącego IL-18
JP5614930B2 (ja) 2005-06-10 2014-10-29 プロメティック バイオサイエンシズ，リミテッド タンパク質結合性リガンドとしてのトリアジン
US9920110B2 (en) * 2011-03-09 2018-03-20 Cell Signaling Technology, Inc. Methods and reagents for creating monoclonal antibodies

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4588585A (en) * 1982-10-19 1986-05-13 Cetus Corporation Human recombinant cysteine depleted interferon-β muteins
US4737462A (en) * 1982-10-19 1988-04-12 Cetus Corporation Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of interferon-β
US4959314A (en) * 1984-11-09 1990-09-25 Cetus Corporation Cysteine-depleted muteins of biologically active proteins
US5116943A (en) * 1985-01-18 1992-05-26 Cetus Corporation Oxidation-resistant muteins of Il-2 and other protein
US5017691A (en) * 1986-07-03 1991-05-21 Schering Corporation Mammalian interleukin-4
US4879111A (en) * 1986-04-17 1989-11-07 Cetus Corporation Treatment of infections with lymphokines
US4965195A (en) * 1987-10-26 1990-10-23 Immunex Corp. Interleukin-7
US4904584A (en) * 1987-12-23 1990-02-27 Genetics Institute, Inc. Site-specific homogeneous modification of polypeptides
DE3902948A1 (de) * 1989-02-01 1990-08-09 Telefunken Fernseh & Rundfunk Verfahren zur uebertragung eines signals
ES2145744T5 (es) 1991-01-18 2008-02-01 Amgen Inc. Procedimientos para tratar las enfermedades inducidas por el factor de necrosis tumoral.
US6117996A (en) * 1995-09-20 2000-09-12 Novo Nordisk A/S Triazine based ligands and use thereof
IL121860A0 (en) * 1997-08-14 1998-02-22 Yeda Res & Dev Interleukin-18 binding proteins their preparation and use
US7220717B2 (en) * 1997-08-14 2007-05-22 Yeda Research And Development Company Ltd. Interleukin-18 binding proteins, their preparation and use
GB9910807D0 (en) * 1999-05-10 1999-07-07 Prometic Biosciences Limited Novel detoxification agents and their use
AU782496B2 (en) 1999-07-13 2005-08-04 Bolder Biotechnology, Inc. Immunoglobulin fusion proteins
IL131047A0 (en) 1999-07-22 2001-01-28 Yeda Res & Dev Use of il-18 inhibitors
SK288032B6 (sk) 2000-02-21 2012-12-03 Merck Serono Sa Use of IL-18 inhibitors for manufacture of medicament for treatment and/or prevention of alcoholic hepatitis
EA007014B1 (ru) 2000-05-05 2006-06-30 Апплайд Резеч Системз Арс Холдинг Н.В. Применение il-18 в качестве диагностического маркера
EA010180B1 (ru) 2001-01-29 2008-06-30 Лаборатуар Сероно Са Применение ингибитора il-18 для приготовления лекарственного средства для лечения и/или профилактики кардиомиопатии
US7524488B2 (en) 2001-03-08 2009-04-28 Ares Trading S.A. Interleukin-18 mutants
ES2334773T3 (es) 2001-05-16 2010-03-16 Yeda Research And Development Co. Ltd. Uso de inhibidores de il-18 para el tratamiento o prevencion de la sepsis.
BR0210007A (pt) 2001-05-25 2004-08-10 Ares Trading Sa Uso de inibidores de il-18 para tratamento ou prevenção de lesões do sistema nervoso central
UA78516C2 (en) 2001-08-10 2007-04-10 Applied Research Systems Use of inhibitors of il-18 for treatment and/or prevention of hypersensitivity disorders, and in particular of delayed-type hypersensitivity
CA2478855C (en) 2002-03-22 2013-12-17 Applied Research Systems Ars Holding N.V. Use of il-18 inhibitors for the treatment and/or prevention of peripheral vascular diseases
JP5171033B2 (ja) * 2003-03-11 2013-03-27 メルク セローノ ソシエテ アノニム ｍＣＭＶＩＥ２プロモーターを含んで成る発現ベクター
ES2384241T3 (es) * 2003-05-13 2012-07-02 Merck Serono Sa Variantes activas de la proteína que fija IL-18 y usos médicos de las mismas
PT1675956E (pt) 2003-10-21 2010-11-04 Merck Serono Sa Sequência mínima de adn que actua como um isolador de cromatina e sua utilização na expressão de proteína
RS50516B (sr) * 2003-11-05 2010-05-07 Ares Trading S.A. Prečišćavanje il-18 vezujućeg proteina
PT1720979E (pt) * 2004-03-01 2007-10-25 Ares Trading Sa Utilização de um meio de cultura de células sem soro para a produção de il-18bp em células de mamífero
US7439336B2 (en) * 2004-06-29 2008-10-21 Ares Trading S.A. Process for the purification of IL-18 binding protein
PL1885753T3 (pl) 2005-06-03 2011-12-30 Ares Trading Sa Wytwarzanie rekombinowanego białka wiążącego IL-18
JP5614930B2 (ja) * 2005-06-10 2014-10-29 プロメティック バイオサイエンシズ，リミテッド タンパク質結合性リガンドとしてのトリアジン

Also Published As

Publication number Publication date
SI1891088T1 (sl) 2012-02-29
PL1891088T3 (pl) 2012-03-30
HRP20110948T1 (hr) 2012-01-31
US8217152B2 (en) 2012-07-10
NO340957B1 (no) 2017-07-31
PT1891088E (pt) 2011-12-19
IL187935A (en) 2015-10-29
CA2610804C (en) 2013-11-19
JP5091127B2 (ja) 2012-12-05
US20080200658A1 (en) 2008-08-21
AU2006256763A1 (en) 2006-12-14
EP1891088A1 (en) 2008-02-27
AU2006256763B2 (en) 2012-08-02
EP1891088B1 (en) 2011-10-19
ES2375831T3 (es) 2012-03-06
CA2610804A1 (en) 2006-12-14
RS52273B (en) 2012-10-31
DK1891088T3 (da) 2012-01-30
ATE529433T1 (de) 2011-11-15
JP2008542432A (ja) 2008-11-27
WO2006131550A1 (en) 2006-12-14
CY1112312T1 (el) 2015-12-09
IL187935A0 (en) 2008-03-20

Similar Documents

Publication Publication Date Title
NO20080131L (no) Fremgangsmate for rensing av IL-18 bindende protein
NO20062545L (no) Fremgangsmate for rensing av IL-18-bindende protein
NO20070483L (no) Prosses for rensing av IL-18 bindende protein.
ATE481482T1 (de) Verfahren zur vorbereitenden rna-reinigung mittels hplc
WO2008087184A3 (en) Process for the purification of fc-containing proteins
WO2007081851A3 (en) Affinity chromatography matrices and methods of making and using the same
NO20076672L (no) Produksjon av rekombinant IL-18 bindingsprotein
DE602004016796D1 (de) Reinigungverfahren für Synthesegas
DK1809663T3 (da) Fremgangsmåde til oprensning af FSH
EP1568710A3 (en) Antibody purification method
WO2007016635A3 (en) Process for the purification of coenzyme q10
WO2009138484A3 (en) Antibody purification process
DK1817342T3 (da) Fremgangsmåde til affinitetsrensning
ATE496935T1 (de) Verfahren zur aufreinigung hydrophober proteine
WO2011090720A3 (en) Purification of proteins
SE0303532D0 (sv) Purification of immunoglobulins
MY157846A (en) Process for the purification of fc-containing proteins
DE602006009015D1 (de) ahren zu ihrer Herstellung.
EP1842908A4 (en) PROCESS FOR PREPARING CLEANED LIPASE
IL199752A0 (en) Purification of taci-fc
EP2129461A4 (en) CLEANING OF IMMUNOGLOBULINS
CY1116631T1 (el) Καθαρισμος πρωτεϊνων με τεχνικη μη-συγγενειας